:Global plasma products market expected to reach US$26b in
2015 (US$11.8b in 2009); of which Asia will account for one quarter."
"To date, NSP has sold 10% of PrIME Biologics Pte Ltd
in return for S$6 million, valuing its PrIME biologics subsidiary at S$60 million (~A$47 million). NSP
has agreed to sell down its shareholding in PrIME to around 60% to be retained by the Company as an investment."
fair value 23c ready for 400% up, page-58
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $25.15K | 5.030M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 18776263 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 10551662 | 4 |
View Market Depth
| Last trade - 10.32am 08/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
